Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-23-015887
Filing Date
2023-04-28
Accepted
2023-04-28 16:35:29
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tern-defa14a-2023.htm DEFA14A 20310
2 GRAPHIC img89441578_0.jpg GRAPHIC 99249
3 GRAPHIC img89441578_1.jpg GRAPHIC 83636
  Complete submission text file 0000950170-23-015887.txt   273452
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39926 | Film No.: 23867209
SIC: 2834 Pharmaceutical Preparations